KIRA6

Overview

KIRA6 is an advanced small-molecule IRE1α RNase kinase inhibitor with an IC 50 of 0.6 µM. KIRA6 can trigger an apoptotic response.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > IRE1

Product Information

• Catalog No.: HY-19708
• CAS No.: 1589527-65-0
• Molecular Formula: C28H25F3N6O
• Molecular Weight: 518.53
• Purity: 98.75%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: ≥ 0.5 mg/mL (0.96 mM); Clear solution
• Availability: In-stock

Source

Original product source